1. Home
  2. CCCC vs IMMR Comparison

CCCC vs IMMR Comparison

Compare CCCC & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.72

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$6.18

Market Cap

216.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
IMMR
Founded
2015
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
185.1M
216.7M
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
CCCC
IMMR
Price
$2.72
$6.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$12.20
$13.50
AVG Volume (30 Days)
2.9M
300.0K
Earning Date
05-06-2026
02-27-2026
Dividend Yield
N/A
4.95%
EPS Growth
16.45
82.69
EPS
N/A
1.90
Revenue
$35,947,000.00
$35,013,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.18
Revenue Growth
1.02
N/A
52 Week Low
$1.09
$5.65
52 Week High
$3.82
$8.15

Technical Indicators

Market Signals
Indicator
CCCC
IMMR
Relative Strength Index (RSI) 51.79 49.14
Support Level $2.35 $5.77
Resistance Level $2.71 $6.39
Average True Range (ATR) 0.24 0.19
MACD -0.07 -0.00
Stochastic Oscillator 15.79 50.81

Price Performance

Historical Comparison
CCCC
IMMR

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

Share on Social Networks: